Pharmacists in Chester, New York


14 Pharmacists found in Chester
female pharmacist

Mrs. Aji Shibu Peter, PHARMACIST


Pharmacist
154 Hambletonian Ave, Chester, NY 10918
845-469-3184    

female pharmacist

Danielle Janiak


Pharmacist
78 Brookside Ave, Chester, NY 10918
845-469-7400    

male pharmacist

Mr. Edward John Norey, RPH


Pharmacist
89 Brookside Ave, Chester, NY 10918
845-469-2916    



female pharmacist

Dr. Francine Weber, PHARMD


Pharmacist
72 Brookside Ave, Chester, NY 10918
845-469-6310    

male pharmacist

Gilbert Goetz, RPH


Pharmacist
78 Brookside Ave, Chester, NY 10918
845-469-7859     845-469-6050

female pharmacist

Helen Wang, PHARM D


Pharmacist
89 Brookside Ave, Chester, NY 10918
845-469-2916     845-469-6462

female pharmacist

Hetal Shah, RPH


Pharmacist
37 Grand View Ter, Chester, NY 10918
845-239-6061    

female pharmacist

Kelly Carroll


Pharmacist
105 Pine Hollow Way, Chester, NY 10918
518-653-9578    

female pharmacist

Miyoung Kim


Pharmacist
78 Brookside Ave, Chester, NY 10918
845-469-7859    

female pharmacist

Patricia A Lardner, PHARMD


Pharmacist
78 Brookside Ave, Chester, NY 10918
845-469-7859    

female pharmacist

Mrs. Pravinaben Suresh Patel, RPH


Pharmacist
89 Brookside Ave, Chester, NY 10918
845-469-2916     845-469-6462

female pharmacist

Stephanie Viray


Pharmacist
89 Brookside Ave, Chester, NY 10918
845-469-2916    

male pharmacist

Mr. Steven Bianco, RPH


Pharmacist
72 Brookside Ave, Chester, NY 10918
845-469-6310    

male pharmacist

Sukhadevan Rampam, R.PH


Pharmacist
78 Brookside Ave, Suite 122, Chester, NY 10918
845-469-7859     845-469-6050


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.